Archives

Boston Scientific Buying Axonics For $3.7 Billion: Details

By Dan Anderson ● Jan 8, 2024

Boston Scientific announced it has entered into a definitive agreement to buy Axonics, a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. The purchase price is $71 in cash per share, reflecting an equity value of about $3.7 billion and an enterprise value of approximately $3.4 billion.

Claris Bio: $57 Million Closed To Improve Corneal Healing Quality

By Annie Baker ● Jan 8, 2024

Claris Bio - a late-clinical stage biotechnology company focusing on corneal disease therapies - has unveiled the company and its lead program, with a total of $57 million invested from Series A investors Novo Holdings A/S, RA Capital and Mass General Brigham Ventures and recent investor Janus Henderson Investors.

Affinity Learning Raises Funding From O’Shaughnessy Ventures

By Amit Chowdhry ● Jan 8, 2024

O'Shaughnessy Ventures LLC - a family office that invests in ambitious seed and pre-seed startups - recently announced that it has invested in Affinity Learning.

Berkeley SkyDeck: How This Fast-Growing Entrepreneurship Accelerator Also Drives The University’s Public Education Mission

By Amit Chowdhry ● Jan 8, 2024

Berkeley SkyDeck is a global hub for entrepreneurship and one of the leading accelerators in the world. Pulse 2.0 interviewed Berkeley SkyDeck executive director Caroline Winnett to learn more.

Raven Cargo: Offering Reliable Freight Shipping To Various Industries And Sizes

By Amit Chowdhry ● Jan 8, 2024

Raven Cargo is a company that provides efficient and reliable freight shipping services catering to various industries and shipment sizes, from expedited to exported loads. Pulse 2.0 interviewed Raven Cargo chief executive officer Lucas Grizz to learn more about the company.

Panorays: Helping Organizations Manage Their Vendor Risk Effectively

By Amit Chowdhry ● Jan 8, 2024

Panorays is a leading provider of innovative third-party security risk management solutions, helping organizations worldwide manage their vendor risk effectively and efficiently. Pulse 2.0 interviewed Panorays CEO and co-founder Matan Or-El to learn more about the company.

PolyAI: Transforming The $70 Billion Enterprise Conversational Assistant Market

By Amit Chowdhry ● Jan 8, 2024

PolyAI is a company that builds enterprise conversational assistants that carry on natural conversations with customers to solve their problems. And the company’s conversational assistants understand customers, regardless of what they say or how they say it. Pulse 2.0 interviewed PolyAI chief operating officer Yan Zhang to learn more about the company.

AskFora: How This Skills-Mapping Platform Is Transforming A $55+ Billion Market

By Amit Chowdhry ● Jan 8, 2024

AskFora creates solutions that help you work better with people you know. By bringing the power of AI to the Future of Work, AskFora’s technology maps the skills of employees and candidates in rapidly evolving talent pools automatically, delivering better outcomes for employers and workers. Pulse 2.0 interviewed AskFora founder Omer Trajman to learn more about the company.

Cubic Transportation Systems: How This Company Delivers Integrated Systems For Fare Collection And Traffic Management

By Amit Chowdhry ● Jan 8, 2024

Cubic Transportation Systems is a leading integrator of payment and information solutions and related services for intelligent travel applications. Cubic delivers integrated systems for transportation and traffic management, delivering tools for travelers to choose the smartest and easiest way to travel and pay for their journeys and enabling transportation authorities and agencies to manage demand across the entire transportation network, all in real-time. Pulse 2.0 interviewed Matt Newsome, Senior Vice President and General Manager for North America at Cubic Transportation Systems, to learn more about the company.

Ludica Health: Developing Solutions To Make A Difference In The Lives Of Seniors

By Amit Chowdhry ● Jan 8, 2024

Ludica Health is a fast-growing startup that is redefining the field of physical rehabilitation and senior wellness through motion capture technology. The company develops cutting-edge solutions to make a difference in the lives of seniors. And the company's products deliver video games that allow individuals with a variety of health concerns to engage in fun, gamified exercises in rehab hospitals and from the comfort of their own homes. Pulse 2.0 interviewed Ludica Health co-founder and CEO Mark Evin to learn more about the company.

Auquan: How This Company Helps Financial Services Extract Timely Intelligence

By Amit Chowdhry ● Jan 8, 2024

Auquan uses AI to transform investment research, KYB, and ESG for financial services. Pulse 2.0 interviewed Auquan founder and CEO Chandini Jain to learn more about the company.

Why Mimecast Is Buying Elevate Security

By Dan Anderson ● Jan 7, 2024

Mimecast - an advanced email and collaboration security company - recently announced its acquisition of Elevate Security, a provider of human risk management solutions. This acquisition strengthens Mimecast’s offerings by providing proactive insights and deeper visibility into human behaviors and risk, helping customers better protect the digital workplace. The financial terms of the deal were not disclosed.

Isomorphic Labs Signs Deal Valued Up To $1.7 Billion With Eli Lilly

By Amit Chowdhry ● Jan 7, 2024

Digital biology company Isomorphic Labs - a company with a goal of redefining drug discovery using the power of AI - recently announced that it has entered into a strategic research collaboration with Eli Lilly and Company.

Knownwell: AIaaS Platform Company Raises $2 Million In Pre-Seed Funding

By Annie Baker ● Jan 7, 2024

Knownwell - a pioneering AIaaS (Artificial Intelligence as a Service) platform company – recently announced the successful closing of a $2 million pre-seed round. This funding round marks a significant milestone in Knownwell's goal of transforming the professional services sector with its cutting-edge Intelligent Enterprise Operating System.

Clarametyx Biosciences: $33 Million Secured To Advance Anti-Biofilm Biologics For Bacterial Infections

By Annie Baker ● Jan 6, 2024

Clarametyx Biosciences - a clinical-stage company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms – recently announced the successful completion of a $33 million Series A round. The Series A financing was led by the Ohio Innovation Fund, with participation from current investors Nationwide Children’s Hospital, Rev1 Ventures, JobsOhio Growth Capital, C Bio Investors, and 1776 Fund.

Nabla: $24 Million Raised To Expand Ambient AI Assistant For Practitioners

By Amit Chowdhry ● Jan 6, 2024

Nabla – a leading ambient AI assistant for practitioners - recently announced the initial close of a $24 million Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures.

Banner Ridge: $2.15 Billion In Oversubscribed Secondary Fund V Closed

By Amit Chowdhry ● Jan 6, 2024

Banner Ridge Partners - a $7.3 billion multi-strategy private equity investment firm - has completed fundraising for Banner Ridge Secondary Fund V (BRP V) at its hard cap with $2.15 billion of total commitments. BRP V is the latest fund to be raised as part of the firm's flagship secondary program.

CRISPR QC: Genetic Medicine Company Closes $10 Million In Funding

By Dan Anderson ● Jan 6, 2024

CRISPR QC, a San Diego-based biotechnology company that has developed the world’s first platform to precisely analyze the quality of the CRISPR/CAS9 gene editing system – has raised $10 million in funding led by Xcellerant Ventures.

Credo Health: Medical Record Retrieval And Analysis Company Closes $5.25 Million In Funding

By Annie Baker ● Jan 6, 2024

Credo Health - a leader in technology for value-based care – recently announced it has successfully secured $5.25 million in series seed funding. FCA Venture Partners led the funding round with existing investors, including Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures.

Why Society Brands Is Buying Primal Life Organics

By Amit Chowdhry ● Jan 5, 2024

Society Brands - a tech-enabled consumer products company built for and by founders – recently announced it has partnered with fellow Northeast Ohio-based Primal Life Organics, an established purveyor of personal care products, to continue to build and expand its direct-to-consumer and retail-based business while advocating “The Clean Beauty Movement.”

Nalu Medical: $65 Million Raised To Advance Treatments For Chronic Neuropathic Pain

By Noah Long ● Jan 5, 2024

Nalu Medical - a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain - recently announced the closing of a $65 million equity financing.

Heart + Paw Raises Significant Strategic Growth Investment From Whistler Capital

By Annie Baker ● Jan 5, 2024

Heart + Paw (H+P) - a veterinary and multi-service pet care company leading the future of pet care in digitally enabled and thoughtfully-designed locations - recently announced a significant strategic growth investment from Whistler Capital Partners, a leading healthcare-focused private equity firm. Heart + Paw will continue to be led by its existing management team, including founder and Chief Veterinary Officer Dr. George Melillo and CEO Dave Lasus. The financial terms were not disclosed.

TCG Crossover: Oversubscribed $1 Billion TCGX Fund II Closed

By Annie Baker ● Jan 5, 2024

TCG Crossover (TCGX) - a life sciences-focused investment firm with a fully flexible mandate to invest in both private and public companies - recently announced the closing of its second fund, TCGX Fund II, with $1 billion in capital, exceeding its original hard cap of $900 million in total capital commitments. This offering attracted strong support from new and existing limited partners, with commitments coming globally from investors in North America, Europe, the Middle East, and Asia.

Moonwalk Biosciences: Genomic Medicine Company Raises $57 Million

By Noah Long ● Jan 5, 2024

Moonwalk Biosciences - a genomic medicine company pioneering precision epigenetic medicines - recently announced the completion of $57 million in seed and Series A financing from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures. The funding will support the continued advancement of Moonwalk’s epigenetic profiling and engineering technology platform and progress its pipeline of epigenetic therapeutics toward the clinic.

Reimagine Care: Strategic Investment From Oncology Ventures Raised

By Noah Long ● Jan 5, 2024

Reimagine Care - a leading provider of virtual-first cancer care - recently announced an investment from Oncology Ventures, a cancer-focused venture capital fund. This funding round marks a significant milestone in the combined pursuit of innovative and patient-centric approaches to cancer care delivery.

Happy Money Signs Strategic Deal With TruStage

By Annie Baker ● Jan 5, 2024

Happy Money - a leading platform for unsecured lending in partnership with credit unions - recently announced the close of a strategic transaction led by TruStage Ventures and other institutional investors. Happy Money remains a privately held company with independent operations under CEO Joe Heck.

Arbital Health: $10 Million Funding And Santa Barbara Actuaries Acquisition

By Dan Anderson ● Jan 5, 2024

Arbital Health - a technology startup focused on accelerating the healthcare industry's transition to value-based care - recently announced the acquisition of Santa Barbara Actuaries and $10 million in Series A financing led by digital healthcare investor Transformation Capital.

Chai: Social AI Platform Company Raises Funding At $450 Million Valuation

By Annie Baker ● Jan 5, 2024

AI platform Chai announced that CoreWeave (the leading specialized GPU cloud provider) will invest in the company, placing Chai at a $450 million valuation. This deal followed shortly after Chai's initial fundraising in June 2023, bringing the total capital invested in Chai to over $10 million.

Exponent Founders Capital Launched With $125 Million To Invest In Early-Stage Companies

By Amit Chowdhry ● Jan 5, 2024

Early stage venture capital firm Exponent Founders Capital launched and disclosed it has raised $125 million to date, including a new $75 million Fund II vehicle that will be deployed across promising inception and early stage companies spanning enterprise software, fintech and payments, infrastructure, applied AI, and vertical SaaS throughout the U.S., Canada, and Europe.

Stanford Byers Center for Biodesign Co-Founder Dr. Josh Makower Joins Sofinnova Partners

By Amit Chowdhry ● Jan 5, 2024

Sofinnova Partners - a leading European life sciences venture capital firm based in Paris, London, and Milan - recently announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.